"10.1371_journal.pone.0086836","plos one","2014-01-28T00:00:00Z","Phillip J Whiley; Michael T Parsons; Jennifer Leary; Kathy Tucker; Linda Warwick; Belinda Dopita; Heather Thorne; Sunil R Lakhani; David E Goldgar; Melissa A Brown; Amanda B Spurdle","QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia; Familial Cancer Service, Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, NSW, Australia; Hereditary Cancer Clinic, Prince of Wales Hospital, Randwick, Sydney, NSW, Australia; Genetics Department, The Canberra Hospital, Canberra, ACT, Australia; kConFab, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; The University of Queensland, UQ Centre for Clinical Research and School of Medicine, and Pathology Queensland, The Royal Brisbane and Womenâ€™s Hospital, Brisbane, Queensland, Australia; Huntsman Cancer Institute and Department of Dermatology, University of Utah, Salt Lake City, Utah, United States of America","Conceived and designed the experiments: PJW ABS MAB DEG SRL. Performed the experiments: PJW MTP SRL. Analyzed the data: PJW SRL DEG MAB ABS. Contributed reagents/materials/analysis tools: JL KT BD HT LW SRL. Wrote the paper: PJW ABS.","David E. Goldgar declares royalties on BRCA1 and BRCA2 testing from Myriad Genetics. The other authors declare that no competing interests exist.","2014","01","Phillip J Whiley","PJW",11,FALSE,5,3,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
